Poly Medicure has reported a strong performance for its third quarter (Q3) earnings, showcasing impressive growth across key financial metrics.
The company posted a net profit of ₹85 crore, marking a remarkable 31% year-on-year (YoY) increase compared to ₹65 crore in the same period last year.
In terms of revenue, Poly Medicure saw a notable 25% growth, with total earnings reaching ₹424 crore, up from ₹339.6 crore in Q3 of the previous year.
The company also witnessed a healthy improvement in its operating performance, as evidenced by its earnings before interest, tax, depreciation, and amortization (EBITDA), which rose by 26.6% YoY to ₹114.3 crore, up from ₹90.3 crore.
Poly Medicure’s margin stood at 27% for the quarter, a slight increase from 26.6% in the same period last year.
In the meantime, Poly Medicure’s stock opened at ₹2,410.75, reaching a high of ₹2,432.95 and a low of ₹2,253.05. The stock has shown significant volatility over the past year, with a 52-week high of ₹3,357.80 and a low of ₹1,373.00.
